Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

AGM Statement

28 Jun 2024 07:00

RNS Number : 2542U
Helios Underwriting Plc
28 June 2024
Β 

Annual General Meeting (AGM)

London, June 28, 2024 - Helios Underwriting, the only publicly traded investment company offering access to a spread portfolio of (re)insurance risk at Lloyd's of London, the world's largest insurance market, will today hold its Annual General Meeting (AGM) at 9.30am at the City of London Club, 19 Old Broad Street, London.

Interim Executive Chairman, Michael Wade, will address Shareholders on the Company's progress and strategic direction. Key extracts from his remarks are outlined below:

An excellent 2023, supported by favourable market conditionsΒ 

The outstanding performance of the Lloyd's market, with a net combined ratio of 84%, Β£5.3 billion in investment returns, and profits of Β£10.7 billion for 2023, underscores the favourable market conditions in which the Company currently operates and which we anticipate will continue into 2024.

For Helios, 2023 was a transformative year reporting a significant rise in profits and return of capital demonstrating the success of the strategy to build the capacity portfolio as the prospects for underwriting profitability improved. Helios's share of the capacity portfolio and strong investment performance have delivered a comprehensive profit of Β£29.9 million for 2023.

In 2024, our gross capacity portfolio has increased to Β£507 million and the retained proportion by Helios shareholders has risen to Β£392 million, although allowing for mid-year participations the overall number will rise to Β£512m and Β£397m respectively.

This growth has been achieved by both using our own capital, and by means of quota share and excess of loss reinsurance and by attracting third party capital to participate alongside Helios on its Lloyd's syndicate capacity portfolio. Deploying the funds raised in the issue the Unsecured Loan Notes in December 2023 geared the Helios capital stack for the 2024 year of account but which we will utilise to reduce costs into 2025 as we form a smaller proportion of the overall syndicate portfolio

Commitment to spread syndicate portfolio strategy

We will continue actively to manage a balanced portfolio of Lloyd's syndicate participations. This strategy also allows us to continue attracting third-party capital, which develops a stream of fee income for Helios, and has already seen success with our 'starter-homes' concept and from the support by existing Members of Lloyd's where they, in effect, rent capacity from us per year of account.

As a part of the overall 2024 syndicate portfolio we took the decision to support recently established or new syndicates where we felt there were exceptional underwriting skill-sets mostly focused upon specialist business accounts providing access to exposures that diversify our portfolio. By definition, the proportion of new syndicate start-ups will reduce into 2025.

We will now manage the operating costs so that the expense ratio of the Company will show a significant reduction in 2025.

In view of the attractive future earnings, we will consult with shareholders over the coming months and look at all options for a capital allocation framework that will balance investment in growth, the gradual reduction of our financial gearing and Shareholder distributions in the form of dividends and share-buy backs.

Β 

Β 

Directorate changes

We recently announced the departure of Martin Reith to pursue other opportunities and wish him well for the future. We thank him for his significant contribution to the Company in building the scale of the syndicate portfolio. On 7th June, we announced that Nigel Hanbury will move to a non-executive role and the Company will seek additional independent non-executives where they can offer experience in Risk and Audit respectively. I am pleased to advise that John Chambers, who has considerable Risk experience, will join as an independent Non-Executive Director immediately following this AGM. We are also seeking to appoint an independent director with audit experience. The Board is committed to best governance practices and we want to ensure a majority of the Board be independent. My own move to interim executive chairman has caused an imbalance of independent directors which we are looking to resolve as soon as is practicable.

Positive outlook

We remain confident that our spread Lloyd's syndicate portfolio for 2024 should generate attractive returns, alongside the exceptional pipeline profits already earned. We aim to attract more third party capital to participate in our 2025 portfolio, and consequently reducing the Helios retained proportion, but with the opportunity of generating a greater fee income. We are uniquely positioned to capitalise on the attractive pipeline presented by the excellent market conditions and maintain our status as the pre-eminent provider of private capital into the Lloyd's market.

Β 

For further information, please contact:

Helios Underwriting plc

Michael Wade - Interim Executive Chairman

Michael.Wade@huwplc.com

+44 203 880 7518

Arthur Manners - Chief Financial Officer

Arthur.Manners@huwplc.com

+44 (0)203 965 6441

Β 

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar

+44 (0)20 7260 1000

Β 

FTI Consulting

Ed Berry / Nathan Hambrook-Skinner

+44 (0)7703 330 199 / +44 (0)7977 817 092

Β 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market writing approximately Β£507m of capacity for the 2024 account. The portfolio provides a good spread of business being concentrated in property & casualty insurance and reinsurance. For further information please visit www.huwplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
AGMQKOBDBBKBOAB
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.